Our research focuses on discovering and engineering antimicrobial peptides (AMPs) from the human microbiome to combat multidrug-resistant bacteria. These peptides show broad-spectrum antibacterial and antibiofilm activity, targeting resistance mechanisms like efflux pumps to restore antibiotic effectiveness.
AI-Powered Drug Discovery and Global Collaborations
We utilize AI-driven screening and computational modeling to accelerate the discovery of both AMP-based and antibiotic therapies. Strategic partnerships with
March 25, 2025